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OBJECTIVES: To analyse the range of existing patient-reported outcome measures 
(PROMs) used in studies of recurrent aphthous stomatitis (RAS) and to evaluate 
their quality properties via the assessment of psychometric properties and 
interpretability. 
MATERIALS AND METHODS: Electronic databases were searched to identify 
relevant publications related to PROMs used in RAS. Publications were selected 
based on predefined criteria. All identified PROMs were then classified by measuring 
concepts and assessed for instrument characteristics and evidence for quality 
properties for RAS patients. 
RESULTS: Twenty-eight PROMs were used in studies of RAS patients. Instruments 
focused upon oral symptoms (n=4), psychosocial status (n=15) and quality of life 
(n=9). Five PROMs (Oral Health related Quality of Life-UK, Chronic Oral Mucosal 
Disease Questionnaire, Oral Health Impact Profile-14, Medical Outcome Study Short 
Form-36, Mumcu’s Composite Index) were found to have some evidence of 
psychometric performance. No PROM showed evidence for interpretability of their 
scores in RAS patients. 
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CONCLUSION: There was a wide range of PROMs used in clinical studies of RAS. 
The majority of these PROMs lack evidence of measurement properties and 
interpretability for RAS patients. Further studies are required to confirm whether 
these instruments are suitable and useful for this patient group.  
 
INTRODUCTION 
The past two decades have witnessed an increasing emphasis on measuring 
disease and treatment outcomes from the patient’s perspective, leading to a steady 
rise in the development of patient-reported outcome measures (PROMs) as validated 
instruments to capture important outcomes directly from a patient (Black and 
Jenkinson, 2009; Devlin and Appleby, 2010). The aim of a PROM is to quantify 
patients’ subjective perception of the disease and treatment impact on their day-to-
day lives in a standardized way (Smith et al, 2005). Routine collection of PROM data 
in clinical settings has been proven to help inform clinical decision-making and 
enhance clinician-patient communication. In addition, a PROM can be a potential 
determinant that reflects the quality of healthcare service (Chen et al, 2013). From 
the perspective of clinical research, a critical step in the clinical trial design is to 
select a well-designed PROM with sufficient evidence of its fundamental quality 
properties including the three psychometric or measurement properties (validity, 
reliability, responsiveness) and interpretability to ensure that the instrument is 
appropriate and useful for a specific patient population (Mokkink et al, 2010). A 
psychometrically sound PROM is an instrument that is valid (able to measure what it 
is intended to measure), reliable (able to produce consistent scores in different 
occasions) and responsive (able to detect change over time if change does exists). 
Apart from psychometric performance of an instrument, scores or outcomes of 
PROMs should also be interpretable or have clinical meanings that are easily 
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understood by both patients and clinicians (Mokkink et al, 2010).   
Little is known about the use of PROM in recurrent aphthous stomatitis (RAS), a very 
common ulcerative condition that is known to cause significant pain and discomfort of 
the oral mucosa (Akintoye and Greenberg, 2014). Its precise aetiopathogenesis 
remains unclear but is most likely multifactorial (Slebioda et al, 2014). RAS is 
characterized by recurrent eruptions of painful solitary or multiple small well-
delineated round or ovoid ulcers with a yellowish or greyish centre and surrounding 
erythematous halo. The ulceration arises spontaneously at intervals of days (in mild 
cases) to months in otherwise well persons, gives rise to no systemic manifestations 
such as fever and heals spontaneously  (Scully and Porter, 2008). Based upon its 
clinical presentation, RAS is classified as minor (MiRAS), major (MaRAS) and 
herpetiform (HU) types. Of all its clinical variants, MiRAS is the most prevalent form 
and is associated with relatively small ulcers (less than 1 cm) that are self-remitting 
and usually resolve within 7 to 14 days. Lesions of RAS usually first appear during 
childhood and adolescence and can hamper a patient’s normal activities including 
food and fluid intake, speech and oral hygiene care, and this may consequently lead 
to psychosocial distress and impaired quality of life (QoL) (Jurge et al, 2006). Given 
the lack of definitive aetiological factors, management of RAS is usually 
symptomatic, and is aimed at alleviating patient’s oral symptoms as well as 
improving patient’s psychosocial status and quality of life (Baccaglini et al, 2011). 
Therefore, a patient-centred instrument that is able to capture the oral symptoms, 
psychosocial status and quality of life in patients with RAS is of great importance for 
accurate disease assessment and management.   
While a clinician-centred RAS-specific clinical scoring system is available (Tappuni et 
al, 2013), very few studies have focussed upon the use and the quality properties of 
PROMs in patients with RAS. Three narrative reviews have reported on the use of 
PROMs in patients with a range of oral mucosal diseases (Ni Riordain and 
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McCreary, 2010; Ni Riordain et al, 2015; Wiriyakijja et al, 2017). There remains, 
however, no critical assessment of the quality properties of PROMs in patient with 
RAS. The aims of the present study are to 1) analyse the range of existing PROMs 
used for the measurement of oral symptoms, psychosocial status, and quality of life 
in patients with RAS, and 2) critically assess their psychometric properties and 
interpretability. 
 
MATERIALS AND METHODS 
A comprehensive review of English language articles in the literature were 
undertaken with the aim to identify all PROM-related clinical studies of defined 
population of participants with RAS. 
 
Search strategies 
A series of structured literature searches were performed on three medical 
databases including the MEDLINE (through PubMed), EMBASE and Web of Science 
Citation Index to retrieve all relevant clinical studies from the published literature from 
1990 until June 2017 due to a substantial rise in the development and psychometric 
validation of PROM since 1990 (Garratt et al, 2002). The pre-defined search terms 
used for this review were comprised of disease keywords (‘recurrent aphthous 
stomatitis’ OR ‘recurrent oral ulcers’) combined with AND to the following keywords 
for each concept domain.  
 
 
1. oral symptoms: ‘pain’ OR ‘discomfort’ OR ‘symptom*’  
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
2. psychosocial status: ‘psych*’ OR ‘anxiety’ OR ‘depress*’ OR ‘stress’ OR  
              ‘mood’ OR ‘emotion*’ OR ‘social’ 
3. quality of life: ‘quality of life’ OR ‘oral health related quality of life’ 
 
Although this review focuses on RAS the term ‘recurrent oral ulcers’ was included in 
the search strategies to ensure a more extensive review of the oral ulceration 
literature. 
 
Criteria for considering studies for this review 
Study types and subjects 
English-language, peered-review original articles involving the development, testing 
of psychometric properties (validity, reliability and responsiveness), documentation of 
interpretability and/or use of at least one validated PROM for the measurement of 
oral symptoms, psychosocial status and quality of life in participants with RAS were 
included. Clinical studies using PROMs as a screening instrument rather than for 
measuring outcomes, clinical studies using ad hoc instrument (instrument developed 
without psychometric testing), review articles, letters, commentaries, editorials or 
abstracts were excluded. 
 
Study subjects with a confirmed diagnosis of RAS, diagnosed based upon previous 
or current history of RAS or clinical presentation of RAS-like oral ulcerations without 
underlying systemic conditions associated with the presence of aphthous-like oral 
ulceration (ALU) were included. Multi-disease studies with results stratified for 
participants with RAS were also included. Participants with diagnosis of the following 
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conditions were excluded: Behcet’s disease, Reiter’s syndrome, Sweet syndrome, 
Ulcerative colitis, Crohn’s disease, Celiac disease, auto-inflammatory syndromes, 
haematological abnormalities (severe anaemia, cyclic or chronic neutropenia), 
recurrent erythema multiforme or any viral infection. 
 
Data extraction 
All identified PROMs were categorized upon their underlying concepts into oral 
symptom-PROMs, psychosocial-PROMs and QoL-PROMs. The number of items, 
subscales or domains, rating scales and score types and ranges of each identified 
PROM were then reviewed. These identified PROMs were subsequently assessed 
for their quality properties for the application in RAS patients. 
The evaluation of the quality properties of the identified PROMs included 
 
1. Validity: defined as the degree to which a PROM measures the construct(s) it 
purports to measure. The assessment of validity includes 
         - Content validity: the extent to which the content of a PROM adequately 
            reflects the proposed construct to be measured. 
         - Construct validity: the extent to which a PROM validly measures the 
            ‘construct’ or the theoretical concept that it purports to measure. 
         - Criterion validity: the extent to which the scores of a PROM adequately   
            relate to another ‘criterion’ measure that is considered to be a ‘gold 
            standard’ in the field of study. 
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    2. Reliability: the degree to which the measurement is free from  
        measurement error. The assessment of reliability includes 
        - Test-retest reliability: the extent to which the same results are obtained   
           on repeated measurement of the same PROM when no change in  
           patient’s status has occurred. 
        - Internal consistency reliability: the degree of inter-relatedness  
          between the items. 
   3. Responsiveness: the ability of a PROM to detect change over time in the    
       construct measured. 
   4. Interpretability: the degree to which one can assign qualitative meaning to  
       a PROM's quantitative scores or change in scores (Mokkink et al, 2010). 
 
RESULTS 
Search results 
Database searches identified 3,169 potentially relevant publications, which included 
duplicates and spurious references. Following the selection criteria, 129 articles were 
ultimately included in this review (Figure 1). Overall, a total of 28 PROMs were 
identified for the assessment of patient reported outcomes in patients with RAS from 
129 publications (detailed in Table 1).  
 
Oral symptom-PROM 
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There were 4 PROMs used for the assessment of RAS symptoms in 100 clinical 
studies, which included three generic instruments (Visual Analog Scale (VAS), 
Numerical Rating Scale (NRS), Graded Chronic Pain Scale (GCPS)) and one 
disease-specific instrument (Mumcu’s composite index). With respect to the type and 
severity of RAS being reported in 100 studies, 63 were MiRAS-specific studies, 2 
included patients with MaRAS (one of these included HU patients) and 35 did not 
report RAS subtypes in their studies. 
 
Regarding generic oral symptom-PROMs, the vast majority of RAS studies (86/100, 
86%) used VAS while NRS were used in twelve studies (12%) and only one study 
(Sherman et al, 2007) used GCPS. There was a wide diversity in the use of word 
descriptors in the VAS and NRS among included studies including ‘pain’ (in 59 of 86 
RAS studies using VAS (68.60%); 9 of 12 RAS studies using NRS (75%)), ‘pain and 
discomfort’ (in 6 of 86 RAS studies using VAS (6.98%)) and many others (Table 2). 
Out of the 86 RAS studies using the VAS, only 33 studies (38.37%) provided clear 
and accurate information, in the relevant material and methods section, regarding the 
use of the instrument and the measurement of results; 34 articles (39.53%) reported 
unclear or incorrect information while 19 articles (22.09%) did not provide any 
information. 
 
Apart from generic instruments, there was one disease-specific instrument identified 
for the assessment of RAS-related pain and other different constructs: Mumcu’s 
composite index (composite index: instrument generating single combined score of 
two or more individual components), which was developed for the assessment of the 
impact of oral ulcer activity in RAS and Behcet’s disease (Mumcu et al, 2009) and 
was used for study outcome measurement in one RAS study (Soylu Özler et al, 
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2016). It consists of 3 different subscales including oral ulcer activity (as reflected by 
the presence or absence of oral ulcers in the previous month; 0 - 1 point), pain 
(measured by VAS; 0 – 5 points) and functional status (assessed the impacts of oral 
ulcers on taste, speaking, and eating/chewing/swallowing on a 5-point Likert-type 
scale; 0 - 4 points), with total score of 10. However, this composite index was 
validated for use only in Turkish population, without any evidence of translation or 
cross-cultural validation for other countries/languages.  
 
Psychosocial-PROMs 
A total of 15 PROMs have been used for the evaluation of psychosocial status in 
patients with RAS from 18 clinical studies. One study reported the inclusion of all 
three RAS clinical variants while the other studies did not report clinical subtypes of 
included participants. All of the PROMs are generic instruments (Table 3), which 
measure different psychological and emotional constructs including anxiety (11 
studies), depression (7 studies), stress (6 studies), distress/psychological symptoms 
(3 studies), coping (1 study) and anger (1 study). The most frequently used 
psychosocial-PROMs in RAS were the Hospital Anxiety and Depression Scale 
(HADS; 5 studies), followed by the State-Trait Anxiety Inventory (STAI; 3 studies). 
 
Quality of life-PROMs 
A total of 9 QoL-PROMs were identified from 17 studies. Sixteen studies were non 
RAS subtype-specific whereas one was MiRAS-specific. Six of the instruments 
assessed oral health-related quality of life (OH-QoL) while three (SF-36, SF-12 and 
WHOQOL-BREF) examined general aspects of quality of life. Of the 6 OH-QoL-
PROMs, one instrument was developed for the use in children aged 11-12 years old. 
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Table 4 provides characteristics of these instruments. The most frequently used QoL-
PROMs in RAS population were the Oral Health Impact Profile-14 (OHIP-14; 9 
studies), followed by the Oral Health-Related Quality of Life-UK (OHQOL-UK; 3 
studies) and the Medical Outcome Study Short Form 36 Health Survey (SF-36; 2 
studies).  
 
Evidence for quality properties of identified PROMs 
Of all identified PROMs, 5 PROMs including 4 QoL-PROMs (SF-36, OHIP-14, 
OHQOL-UK and COMDQ) and the Mumcu’s composite index had undergone 
psychometric testing in RAS patients but only the COMDQ was found to have good 
psychometric evidence on all main psychometric properties (validity, reliability, 
responsiveness) in patients with RAS. Mumcu’s composite index was examined for 
its validity and reliability in Turkish patients with RAS (Mumcu et al, 2009). Three 
other QoL-PROMs including SF-36, OHIP-14 and OHQOL-UK were investigated only 
for their internal consistency reliability in Turkish patients with RAS (Mumcu et al, 
2006), with results showing high Cronbach’s α coefficient (≥ 0.92) in all instruments. 
However, other psychometric properties including validity and responsiveness in 
these QoL-PROMs have yet been examined in a RAS population. Table 5 
summarises the psychometric testing of the reviewed PROMs. Importantly, none of 
the PROMs used in RAS patients has evidence or documentation for interpretability 
of their scores in this patient population. 
 
 
 
DISCUSSION 
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Recurrent aphthous stomatitis is a common oral ulcerative condition associated with 
pain and other oral symptoms, which can have a significant negative impact upon 
normal oral functioning, psychosocial functioning and OH-QoL in affected individuals 
(Llewellyn and Warnakulasuriya, 2003; Tabolli et al, 2009). Therefore, in the clinical 
evaluation of patients with RAS, it is of paramount importance to assess the effects 
of this oral condition and its treatment from the perspective of the patient. The 
selection of an appropriate instrument to measure subjective RAS-related patient-
reported outcomes requires careful consideration of the psychometric properties as 
well as the interpretability of the instruments. The present study reviewed the use of 
PROMs in clinical studies of patient with RAS as well as published evidence 
supporting the psychometric properties and interpretability specifically for this patient 
population. 
 
In the present study three generic oral symptom-PROMs including the VAS, NRS 
and GCPS were used in patients with RAS, with VAS being the most frequently used 
instrument. Nevertheless, further investigation into the use of these instruments in 
the RAS literature revealed inconsistencies in reporting the type of oral symptoms 
measured by VAS, as shown by a wide spectrum of different word descriptors for 
VAS including “pain”, “burning sensation”, “discomfort”, “irritation” and many others 
(Table 2). This study heterogeneity makes it difficult to pool VAS data for the 
comparison between studies and meta-analysis. Also, we observed that only 38% of 
studies of RAS provided clear instruction regarding the use of VAS in the 
methodology section, whilst the information in the remaining studies on VAS was 
either absent, unclear or inaccurate; for instance, 27 studies using VAS (31.40%) 
stated that “patients rated their symptoms on a scale from 0 to 10” , which appear to 
reflect NRS rather than VAS, and 7 studies using VAS (8.14%) used different range 
of numerical scale including 1-10 (5 studies), 0-5 (1 study) and 0-4 (1 study). Whilst 
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both VAS and NRS have been widely used in clinical studies of RAS, neither has 
been investigated for psychometric performance specifically for patients with RAS. 
We would suggest that further testing of the psychometric properties of VAS and 
NRS in the RAS population is recommended.  
 
Regarding the assessment of psychosocial status, anxiety and depression were the 
most frequently evaluated concepts in RAS patients, and the HADS, STAI and BDI 
were the most commonly used psychosocial-PROMs in the RAS literature. All three 
measures have been validated in a general population (Spielberger and Gorsuch, 
1983; Beck et al, 1988; Snaith, 2003); nevertheless, all of them lack psychometric 
evidence in the RAS population. There were a few instruments used for assessing 
other psychosocial constructs in individuals with RAS, and again there was no 
published evidence of their psychometric testing or interpretability in this patient 
population. Overall, the present findings raise concerns as to whether these 
instruments are indeed relevant to RAS patients and if they are suitable for 
assessing the psychosocial status of individuals with RAS.  
 
Evaluation of QoL in patients with RAS is also crucial. QoL-PROMs used in clinical 
studies of RAS population can be classified into OH-QoL-PROMs and generic QoL-
PROMs. The present study identified 6 OH-QoL PROMs, but only three have had 
their psychometric properties tested in the RAS population: the OHIP-14, OHQOL-
UK and COMDQ. OHIP-14 is the most frequently used PROMs for the assessment 
of QoL in the RAS literature. This PROM was initially developed for use in older 
Australian adults and is a shortened version of the original OHIP-49. It contains 14 
items with a subset of 2 questions for each of the 7 domains of OH-QoL, based upon 
Locker’s conceptual framework of oral health (Locker, 1988; Slade and Spencer, 
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1994). The development of OHQOL-UK was based on an adult UK population’s 
perceptions of how oral health affects quality of life (McGrath and Bedi, 2003). 
Therefore both OHIP-14 and OHQOL-UK were developed without the input from 
patients with RAS and therefore may not be able to capture all relevant aspects 
associated with the disease and related treatment. COMDQ is an oral medicine-
specific PROM developed for the assessment of quality of life in patients with chronic 
oral mucosal disease including RAS (Ni Riordain et al, 2011). It is the only validated 
QoL-PROM with input from patients with RAS during its development process. In 
addition, COMDQ has the highest number of psychometric studies for patients with 
RAS compared to the other OH-QoL PROMs. Regarding the measurement of 
general aspect of quality of life, only two PROMs have been used in studies of RAS 
patients including SF-36, SF-12 and QHOQOL-BREF, with only the SF-36 having 
some psychometric evidence tested for use in patients with RAS.  
 
We also identified one oral ulcer composite index, which aims to determine the 
impact of oral ulcer activity in patients with RAS and BD (Mumcu et al, 2009). This 
index, however, has not been widely adopted for use in clinical research of RAS, and 
apart from Turkish original language, there is no evidence of translation nor of 
cultural validation of this index. In addition, the rationale behind weights of three 
subscale scores to generate total composite index score appears to be unclear. 
Further validation studies for this composite index are recommended.  
 
 
 
We found that there are no studies reporting the interpretability of any PROM used in 
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clinical research of patients with RAS, and this casts doubts on the clinical 
meaningfulness of the PROM results in clinical studies of patients with RAS. 
Interpretability refers to what the scores or change scores mean in clinical context, 
which facilitates better understanding of PROM results (Mokkink et al, 2010). The 
numerical scores produced from PROMs should be easily translated into clinically 
meaningful information, relevant to patients, clinicians and researchers. An 
interpretability parameter such as the minimal important difference (MID), the 
smallest magnitude of change in PROM scores that is important or meaningful to 
patients, can therefore facilitate clinical interpretation of these scores. Although MID 
for improvement of OHIP-14 in Behcet’s disease was previously determined in a 
Turkish study by Hayran et al (2009), this parameter has yet to be determined in 
group of patients with RAS. There is thus a need for further studies determining 
interpretability of PROMs in patients with RAS. 
 
The goal for RAS management is usually to minimize oral symptoms and improve 
patient’s oral functioning and quality of life. Although different groups of medications 
are available for RAS patients, there is currently no robust evidence supporting the 
efficacy of any of these medications, and future larger randomized placebo-controlled 
trials (RCTs) are required. These RCTs will require the careful selection of validated 
outcome measures, both clinician-centred and PROMs. Although the present study 
identified that some PROMs showed appropriate psychometric properties for use in 
clinical studies of RAS, there is currently a lack of uniformity regarding the choice of 
outcome measures including both PROMs and clinical scoring systems across the 
RAS literature (Brocklehurst et al, 2012). The comprehensive development of a core 
outcome set (COS) for clinical trials of RAS has been initiated and presented by 
Taylor et al at the recent European Association of Oral Medicine (EAOM) conference 
in 2016. The methodology incorporated both patients with RAS (n=6) and experts 
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(n=70), leading to a COS of 13 core outcomes for interventional studies in RAS. This 
COS includes all 6 key outcomes highlighted by patients namely, ulcer size, ulcer 
duration, frequency of ulcer attack, number of ulcers, pain and diet. The use of COS 
for RAS will improve the quality and uniformity of data in future clinical trials, allowing 
comparison between treatments and data pooling in systematic reviews and meta-
analyses. 
 
In conclusion, there was a wide diversity of PROMs used in clinical studies of RAS, 
which include instruments for oral symptoms, psychosocial status and QoL. The 
majority of these PROMs lack evidence of measurement properties and 
interpretability for RAS patients. Further studies are required to confirm whether 
these instruments are suitable and useful for this patient group.  
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Table 1 Types (by concepts measured), acronyms and frequency of use of PROMs 
in clinical studies of patients with RAS 
Instrument type and name frequency of use 
PROMs assessing oral symptoms  
  Symptoms  
    Visual Analog Scale (VAS) 86 
    Numerical Rating Scale (NRS) 12 
    Graded Chronic Pain Scale (GCPS) 1 
  Pain, functional status and oral ulcer activity  
    Mumcu’s composite index (CI) 1 
PROMs assessing psychosocial status  
  Anxiety (only)  
    State-Trait Anxiety Inventory (STAI) 3 
    Beck Anxiety Inventory (BAI) 1 
    Self-Rating Anxiety Scale (SAS) 1 
  Depression (only)  
    Beck Depression Inventory (BDI) 2 
    Quick Inventory of Depressive Symptomatology (QIDS-SR16) 1 
  Stress (only)  
    Recent Life Change Questionnaire (RLCQ) 2 
    Lipp's Inventory of Stress Symptoms of Adults (LISS) 1 
    Symptoms of Stress List (SSL) 1 
    Test of Recent Experience (TRE) 1 
  Anxiety and depression  
    Hospital Anxiety and Depression Scale (HADS) 5 
  Anxiety and anger  
    State-Trait Personality Inventory (STPI) 1 
  Distress/psychological symptoms  
    General Health Questionnaire-12 (GHQ-12) 1 
    General Health Questionnaire-28 (GHQ-28) 1 
    Symptom Checklist (SCL-90) 1 
  Coping  
    Ways of Coping Questionnaire (WCQ) 1 
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PROMs assessing quality of life  
  Oral health related quality of life  
    Oral Health Impact Profile-14 (OHIP-14) 9 
    Oral Health-Related Quality of Life-UK (OHQOL-UK) 3 
    Oral Health Impact Profile-49 (OHIP-49) 1 
    Oral Impacts on Daily Performances (OIDP) 1 
  Oral health related quality of life specific to chronic oral mucosal diseases  
    Chronic Oral Mucosal Disease Questionnaire (COMDQ) 1 
  Oral health related quality of life specific to children   
    Child Oral Impacts on Daily Performances (Child-OIDP) 1 
  General health related quality of life  
    Medical Outcome Study Short Form 36 Health Survey (SF-36) 3 
    Medical Outcome Study Short Form 12 Health Survey (SF-12) 1 
    The World Health Organization Quality of Life-BREF (WHOQOL-BREF) 1 
 
 
Table 2 Word descriptions used in VAS and NRS in the studies assessing oral 
symptoms of RAS 
Word descriptors frequency 
Visual analog scale (VAS)  
  pain 59 
  pain and discomfort 6 
  stimulated/challenged/evoked pain A 5 
  contact pain B 4 
  idiopathic/non-contact/spontaneous pain 4 
  discomfort 3 
  pain and burning sensation 3 
  pain before meals 3 
  soreness 3 
  pain before bedtime 2 
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  discomfort during chewing 
  discomfort during speaking  
  functional complication C  
  irritation 
  oral symptoms D 
  pain and irritation  
  tingling  
1 
1 
1 
1 
1 
1 
1 
Numerical rating scale (NRS)  
  pain 9 
  pain during tooth brushing 1 
  spontaneous pain 1 
  stimulated pain E 1 
A: stimulated pain (N = 5; orange juice-stimulated pain [3], citric acid-stimulated pain [1], hot saline-
stimulated pain [1]) 
B: contact pain (N = 4; pain immediately after laser treatment [2], pain after irritating ulcer with 
periodontal probe [2]) 
C: functional complication = interruption of aphthous ulcers with normal daily activities i.e.  speaking, 
chewing and brushing 
D: oral symptoms i.e. oral pain, difficulty to eat and difficulty to sleep 
E: pain after swabbing ulcer with a saturation of sodium chloride and distilled water 
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Table 3 Characteristics of PROMs assessing psychosocial status in clinical studies of patients with RAS 
Name 
Items 
(N) 
Concept Subscale (N items) 
Rating 
scale 
Score types and range 
Subscales Total Others 
  BAI 21 Anxiety  Anxiety (21) 4-point scale 
(0-1-2-3) 
 0-63  
  BDI, BDI-II 21 Depression Depression (21) 4-point scale 
(0-1-2-3) 
 0-63  
  GHQ-12 12 Distress Distress (12) 4-point scale 
(0-0-1-1 or  
0-1-2-3) 
 0-12  
0-36 
 
  GHQ-28 28 Distress Somatic symptoms (7); Anxiety and insomnia (7); Social dysfunction (7);  
Severe depression (7) 
4-point scale 
(0-0-1-1 or  
0-1-2-3) 
0-7 
0-21 
0-28 
0-84 
 
  HADS 14 Anxiety,  
depression 
Anxiety (HADS-A) (7); Depression (HADS-D) (7) 4-point scale 
(0-1-2-3) 
0-21   
  LISS 56 Stress Phase: Alert (Q1) (16); Resistance amd  Near-exhaustion (Q2) (16); Exhaustion (Q3) 
(24) 
2-point scale 
(0-1) 
0-15 (Q1, 2) 
0-23 (Q3) 
  
  QIDS-SR16 16 Depression Depression (16) 4-point scale 
(0-1-2-3) 
 0-27  
  RLCQ 68 Stress Stressful life events (91) 2-point scale 
(0-life 
change 
units) 
 ✓ 
(total life 
change 
units) 
No of 
events 
  SAS 20 Anxiety Anxiety (20) 4-point scale 
(1-2-3-4) 
 20-80  
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  SCL-90 90 Psychological 
 symptoms 
Somatisation (SOM); Obsessive-compulsive behavior (O-C); Interpersonal sensitivity (I-
S); Depression (DEP); Anxiety (ANX); Hostility (HOS); Phobic anxiety (PHOB); Paranoid 
ideation (PAR); Psychoticism (PSY) 
5-point scale 
(0-1-2-3-4) 
✓  GSI* 
PST* 
PSDI* 
  SSL 59 Stress Stress (59) 4-point scale 
(0-1-2-3) 
 0-177  
  STAI 40 Anxiety State anxiety (STAI-S) (20); Trait anxiety (STAI-T) (20) 4-point scale 
(1-2-3-4) 
20-80   
  STPI 80 Anxiety, anger State anxiety (10); Trait anxiety (10); State anger (10); Trait anger (10); State curiosity 
(10); Trait curiosity (10); State depression (10); Trait depression (10) 
4-point scale 
(1-2-3-4) 
10-40   
  TRE 42 Stress Vital events (42) 2-point scale 
(0-life change 
units) 
 0-600  
  WCQ 66 Coping Confrontive coping (6); Distancing (6); Self-controlling (7); Seeking social support (6); Accepting 
responsibility (4); Escape-Avoidance (8); Planful problem solving (6); Positive reappraisal (7) 
4-point scale 
(0-1-2-3) 
✓     
*Abbreviation: GSI = Global Severity Index (mean of all subscale scores); PST = Positive Symptom Total (number of items with score > 0); PSDI = Positive Symptom Distress Index (the sum of all 
item  
                        values divided by PST) 
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Table 4 Characteristics of PROMs assessing quality of life in clinical studies of patients with RAS 
Name Items 
(N) Concept Subscale (N items) 
Rating scale Score types and range 
 Subscales Total Others 
  Child-OIDP 8 OHQOL 
specific to 
children 
Eating (1); Speaking (1); Cleaning teeth (1); Smiling (1); Emotional stability (1); 
Relaxing (1); Doing schoolwork (1); Social contact (1) 
4-point scale 
on frequency 
and severity 
(0-1-2-3) 
 
 Total (0-100) 
(each item 
score:  
frequency x 
severity x 
100/72) 
 
  COMDQ 26 OH-QOL 
 specific to  
 COMD 
Pain & function limitation (PF) (9); Medication & treatment (MT) (6);  
Social & emotional (SE) (7); Patient support (PS) (4) 
5-point scale 
(0-1-2-3-4) 
0-36 for PF  
0-24 for MT 
0-28 for SE 
0-16 for PS 
0-104  
  OHIP-14 14 OH-QOL Functional limitation (FL) (2); Physical pain (PhyP) (2); Psychological discomfort 
(PsyD) (2); Physical disability (PhyDis) (2); Psychological disability (PsyDis) (2); Social 
disability (SDis) (2); Handicap (H) (2) 
5-point scale 
(0-1-2-3-4) 
 0-56 
(Severity) 
Extent* 
  OHIP-49 49 OH-QOL Functional limitation (FL) (9); Physical pain (PhyP) (9); Psychological discomfort 
(PsyD) (5); Physical disability (PhyDis) (9); Psychological disability (PsyDis) (6); Social 
disability (SDis) (5); Handicap (H) (6) 
5-point scale 
(0-1-2-3-4) 
0-36 for  
FL, PhyP, PhyDis 
0-24 for PsyDis, H   
0-20 for PsyD, SDis  
0-196  
  OHQOL-UK 16 OH-QOL Physical effects/impacts (Phy-E/I) (6); Social effects/impacts (S-E/I) (5); Psychological 
effects/impacts (Psy-E/I) (5) 
5-point scale 
(1-2-3-4-5 for 
effects and 0-
1-2-3-4 for 
impacts) 
6-54 for Phy-E/I 
5-45 for S-E/I, Psy-
E/I 
16-144  
  OIDP 8 OH-QOL Eating (1); Speaking and pronouncing clearly (1); Cleaning teeth (1); Sleeping and 
relaxing (1); Smiling without embarrassment (1); Maintaining emotional state (1); 
Enjoying contact with other people (1); Carrying out major school work (1) 
6-point scale 
on frequency 
and severity 
 Total (0-100) 
(each item 
score:  
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(0-1-2-3-4-5) frequency x 
severity x 
100/150) 
  SF-12 12 GH-QOL Physical functioning (PF) (2); Role physical (RP) (2); Bodily pain (BP) (1); General 
health (GH) (1); Vitality (VT) (1); Social functioning (SF) (1); Role emotional (RE) (2); 
Mental health (MH) (2) 
2- to 6-point 
scale 
  PCS-12 
MCS-12 
  SF-36 36 GH-QOL Physical functioning (PF) (10); Role physical (RP) (4); Bodily pain (BP) (2); General 
health (GH) (5); Vitality (VT) (5); Social functioning (SF) (2); Role emotional (RE) (3); 
Mental health (MH) (5); Health transition (HT) (1) 
2- to 6-point 
scale 
0-100 (transformed 
 from raw score) 
0-100 
(transformed 
 from raw 
score) 
PCS* 
MCS* 
  WHOQOL-     
   BREF 
26 GH-QOL Overall quality of life and general health (Ov) (2); Physical health (Ph) (7); 
Psychological (Ps) (6); Social relationships (So) (3); Environment (En) (8) 
5-point scale 
(1-2-3-4-5) 
7-35 for Ph  
6-30 for Ps 
3-15 for So 
8-40 for En 
  
*Note: Extent = N of items reported fairly often (3)/very often (4); GH-QOL = general health related quality of life; OH-QOL = oral health related quality of life; PCS = Physical    
 
           Component Summary; MSC = Mental Component Summary 
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Table 5 Summary of psychometric properties of identified PROMs in clinical studies of patients with RAS 
Authors PROMs 
Questionnaire 
language/count
ry 
Main Methods of 
Evaluation 
No of 
patients Major reported outcomes 
Mumcu et al, 
2006 
OHIP-14 Turkish/Turkey Internal consistency 24 Cronbach's α = 0.95 
 OHQOL-UK Turkish/Turkey Internal consistency 24 Cronbach's α = 0.97 
 SF-36 Turkish/Turkey Internal consistency 24 Cronbach's α = 0.92 
Mumcu et al,  
2007 
OHIP-14 Turkish/Turkey Structural validity 28 FA revealed three subscales and 
explained 66.49% of overall 
variance in patients with active 
oral ulcers 
Mumcu et al, 
2009 
Mumcu’s 
composite 
index (CI) 
Turkish/Turkey Convergent validity 
(correlation with VAS for 
pain, number of oral ulcers, 
frequency of relapses); 
Discriminant validity between 
patients with oral ulcers (RAS 
and BD) and patients with 
dental infections; Internal 
consistency 
31 Moderate to good convergent 
validity of total CI score with VAS 
for pain (r = 0.90), number of oral 
ulcers (r = 0.77) and frequency of 
relapse (r = 0.51); No CI score in 
patients with dental infections; 
Cronbach's α for functional 
disability score = 0.75 
Ni Riordain and  
McCreary, 
2011 
COMDQ English/Ireland Convergent validity 
(correlation with VAS for pain 
and OHIP-14), Discriminant 
validity between patients with 
and without COMD, Internal 
consistency 
12 Good convergent validity with 
VAS for pain (r = 0.883) and 
OHIP-14 (r = 0.819); Significant 
difference in COMDQ scores 
between patients with and without 
COMD; Cronbach's α = 0.929 
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Ni Riordain and  
McCreary, 
2012 
COMDQ English/Ireland Test-retest reliability,  
Responsiveness to change  
? Good test-retest reliability  
(ICC = 0.81); COMDQ is 
responsive to changes in the 
patient's overall conditions 
Li and He, 
2013 
COMDQ Chinese/China Structural validity; Internal  
consistency; Test-retest 
reliability 
84 EFA extracted four factors  
(consistent with original english 
version) and all items 
demonstrated adequate factor 
loadings; Cronbach's α = 0.894; 
ICC of total COMDQ scores = 
0.83 
Ni Riordain et 
al, 2016 
COMDQ English/UK Convergent validity 
(correlation with VAS and 
OHIP-14), Internal 
consistency  
42 Moderate to good convergent 
validity with VAS and OHIP-14; 
Cronbach's α = 0.93 
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